Mahalo Health

What Mahalo Health does

Mahalo Health (legal entity Mahalo Digital Ventures, Inc., with a Singapore operating entity Mahalo Digital Ventures Pte Ltd) provides a unified digital health platform that combines digital therapeutics (DTx) development with decentralized, hybrid, and traditional clinical trial execution on a single infrastructure. The platform is built on Google Cloud Platform with data centers in the United States, Singapore, United Kingdom, Netherlands, and Australia, and integrates with 260+ connected devices, EHR systems, CTMS, and clinical labs to enable real-time biomarker collection, electronic data capture, eConsent, ePRO, randomization, virtual sites, and remote patient monitoring. Core AI components include a Predictive Health Engine, a Behavior Change Engine, a Notification Engine, and a Clinical AI Flywheel that applies NLP and anomaly detection to recruitment, protocol deviation detection, and adverse event surveillance. The product surface spans eight therapeutic areas — Diabetes, Cognitive Health, Cardiovascular, Musculoskeletal Disorders, Mental Health, Oncology, Rare Diseases, and NASH.

Mahalo sells primarily to biopharmaceutical and medical technology companies, with secondary use-case segments in NASH care, rare disease organizations, and oncology centers. Revenue is generated through annual enterprise SaaS subscriptions that bundle platform licensing with managed services for privacy, security, regulatory compliance monitoring, and Level II/III support, supplemented by professional services for custom software development on top of the platform, including patient companion apps, Software as a Medical Device (SaMD), dosing algorithms, and web services. Go-to-market is direct enterprise sales (field and inside) executed from offices in Austin, TX and Singapore, supported by a content-led marketing motion (Insights blog, white papers, LinkedIn presence) and demo-request funnels. Pricing is not publicly disclosed; contracts are custom and scoped to usage and regulatory requirements.

The platform is positioned under a Quality Management System for regulated drugs, devices, and software, and carries an unusually broad compliance footprint: ISO 27001 (since 2020), ISO 9001, FDA 21 CFR Part 11, HIPAA, GDPR, ICH E6 GCP, HITRUST CSF, ISO 13485:2016, IEC/ISO 62304:2015, MDSAP, and HDS. The company cites quantitative outcomes of 3–6 month time-to-market (versus typical 12–24 months), up to 70% development effort reduction, and 40% data lock time reduction in medical device trials. As of the available data, no funding rounds have been disclosed and only four customer references are public (MyHealthierBrain, Klinify, Nightingale, and NUS), indicating an early commercial stage relative to its technical scope.

Name

Mahalo Health

Legal name

Mahalo Digital Ventures, Inc.

Website

https://mahalo.health

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Mahalo Health provides a unified, regulation-grade digital health platform that enables biopharma and medtech companies to develop digital therapeutics and run decentralized clinical trials on pre-built modules, with AI-driven patient engagement tools spanning eight therapeutic areas.

Ownership category

akta.pro rank

Product category

Digital Health Clinical Trial Software

NAICS

Software Publishers (5132), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182)

SIC

Services-Prepackaged Software (7372), Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Decentralized/Hybrid Trial Enablement (DCT) Platforms (HLACAOAL)

akta.pro secondary industries

eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB), Electronic Data Capture (EDC) Platforms (HLACAOAA), Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL), Medication Adherence & Therapy Management Platforms (refills, reminders, MTM) (HLALAIAG)

Keywords

• Digital therapeutics platform
• Decentralized clinical trials
• Clinical research software
• EClinical solutions
• Digital health app development

Headquarters

HQ city

Singapore

HQ country

Singapore

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Platform License / SaaS Subscription: Mahalo operates as a SaaS/platform company offering annual subscriptions for platform access. The platform license includes managed service for support, maintenance, privacy and security monitoring, regulatory compliance updates, and performance monitoring with Level II and III support.
2. Professional Services: Expert engineering team supports customers in developing and deploying custom software on top of Mahalo, including patient companion apps, Software as a Medical Device (SaMD), dosing algorithms, and web services.
3. Managed Services: Included in platform license, the managed service covers ongoing privacy, security, regulatory monitoring, platform performance monitoring, and technical support.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Mahalo Health provides a unified digital health platform for biopharma and medtech companies to rapidly build white-label digital health apps and run decentralized clinical trials. Its modules cover clinical research (eClinical, EDC, eConsent, ePRO, Virtual Sites, Randomization and Shipping) and digital therapeutics features (wearables integration, eDiary, microlearning, medication management, digital prescriptions), underpinned by AI engines for prediction, behavior change, and notifications. The platform is sold via annual enterprise subscriptions with bundled managed services and optional professional services.

Product overview

Mahalo Health is a unified digital health platform that accelerates digital health app development and clinical research through a platform-plus-modules architecture. The core Mahalo Unified Data Platform provides connectivity, data management, and analytics capabilities, supplemented by clinical trial modules (eClinical, EDC, eConsent, ePRO, Virtual Sites, Randomization and Shipping, Medical Records) and digital health app accelerators (Digital Health Diary, Wearables, Questionnaires, Microlearning, Coaching and Community, Medication Management, Digital Prescriptions). AI capabilities are delivered through the Predictive Health Engine, Behavior Change Engine, and Notification Engine. The platform serves eight therapeutic areas: Diabetes, Cognitive Health, Cardiovascular, Musculoskeletal Disorders, Mental Health, Oncology, Rare Diseases, and NASH. The platform is built under a Quality Management System to support regulated drugs, devices, and software.

Differentiator

Problem solved

Functional benefit

Products and services

• Mahalo Unified Data Platform Core backend infrastructure that aggregates data from multiple sources and integrates with EHRs and other IT systems, providing a unified view of patient information across the healthcare ecosystem; intended for biopharma and medtech digital health programs.
• eClinical (Decentralized Clinical Research Platform) Comprehensive platform for conducting virtualized and distributed clinical studies with improved data collection, patient recruitment, and patient retention; designed for biopharma and medtech sponsors running traditional, hybrid, or decentralized trials.
• Electronic Data Capture (EDC) Digital system for storing all survey and study data on one platform, supporting electronic case report forms (eCRFs) with built-in validation and real-time data entry for clinical trial sponsors.
• eConsent Digital consenting module enabling recruitment, screening, and consent of participants digitally with fully transparent and traceable time/date stamped process; intended for clinical trial sponsors.
• ePRO (Electronic Patient-Reported Outcomes) Self-serve study data collection module enabling participants to report outcomes directly, supporting automated capture of images, audio, and video for clinical trials and digital therapeutics.
• Medical Records and Tests Module that fetches medical histories and lab results from EHRs, enabling seamless integration of clinical data into the platform for trial sponsors and care programs.
• Virtual Sites Scheduling and telehealth appointment module supporting 24/7 appointment booking and multi-party video calling for virtual clinical visits in decentralized trials.
• Randomization and Shipping Module for randomizing participants and delivering medication, supporting clinical trial logistics for sponsors running decentralized studies.
• DTx Development (Digital Therapeutics Development Platform) Platform accelerator for developing digital therapeutics, allowing rapid deployment of white-label digital health apps with prebuilt modules for biopharma and medtech sponsors.
• Digital Health Diary (eDiary) eDiary module with sleep, food, water, and weight goals for tracking patient journey in clinical trials with remote capabilities.
• Wearables and Connected Devices Module integrating with 260+ connected devices to fetch smartwatch, smart scale, and device data for real-time biomarker collection across clinical and digital therapeutic programs.
• Questionnaires Module for creating health surveys with different question types, completion parameters, and response analysis capabilities for trials and digital therapeutics.
• Microlearning Educational content module with 80% higher retention rates, enabling engagement with contextual lessons and training materials for patients in digital therapeutics programs.
• Coaching and Community Communication tools and coaching network enabling coaches to track participant progress, view statistics, send files, videos, content, quizzes, and reminders.
• Medication Management Digital tools to increase patient compliance, tracking and managing therapy and medication history.
• Digital Prescriptions Module enabling prescription and insurance billing for drugs and digital therapeutics.
• Predictive Health Engine AI-powered engine that captures, predicts, and diagnoses disease and worsening health biomarkers using advanced analytics.
• Behavior Change Engine AI-powered engine providing notifications, recommendations, and follow-ups that promote behavior change in patients.
• Notification Engine Engine for sending messages at the right time using push, SMS, or email notifications to improve patient engagement.
• Security and Compliance Security infrastructure covering data security, HIPAA, GCP, ISO27001, GDPR compliance with audit trails and encryption.

Quantifiable outcome

• Time to market reduced from months/years to 3-6 months
• +2 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability12 records

Feature10 records

Partnerships

One partnership is on record.

• Google Cloud PlatformcoreTechnology or IntegrationMahalo applications run on fully managed Google Cloud Platform infrastructure, operating in US, Singapore, UK, Netherlands, and Australia regions. All hosting platforms are certified for ISO27001 and compliant with HIPAA and GDPR standards.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Veeva Systems: Enterprise life sciences cloud platform including Vault CTMS, Vault EDC, and ePRO — directly comparable to Mahalo's clinical trial and regulated digital health modules.
• Signant Health: Patient-centered clinical trial technology (eCOA, eConsent, patient engagement) — directly comparable to Mahalo's ePRO and behavior-change engines.
• Curebase: DCT platform combining eCOA/eConsent, virtual sites, and connected devices — directly comparable to Mahalo's eClinical and wearables modules.
• Science 37: Pure-play decentralized clinical trial operator with a patient-facing Metasite app and eCOA stack — directly comparable to Mahalo's DCT offering.
• ObvioHealth: Digital DCT provider with app-based ePRO, telehealth, and connected device data — comparable to Mahalo's integrated wearables-and-app model.
• Clario: Specialist in eCOA, medical imaging, and decentralized trial endpoint services — overlaps directly with Mahalo's ePRO and remote biomarker collection modules.
• THREAD: Decentralized clinical trial platform with eCOA/eConsent and telehealth — directly comparable to Mahalo's Virtual Sites and patient-facing modules.
• Medidata Solutions (Dassault Systèmes): Industry-leading unified EDC/CTMS/eCOA/eConsent DCT platform; the dominant direct competitor to Mahalo's eClinical offering for biopharma clinical trials globally.

Broad incumbents

• IQVIA: Global CRO and life sciences technology vendor with EDC, eCOA, DCT and Real World Evidence offerings — broad incumbent competing with Mahalo on full-stack trial technology.

Emerging players

• Biofourmis: AI-driven RPM and digital therapeutics platform with wearable biomarker collection — overlaps with Mahalo's Predictive Health Engine and wearables modules.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/mahalohq
• LinkedInlinkedin.com/company/mahalo-health

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mahalo Health